The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and therapeutic role of raloxifene hydrochloride are reviewed. Raloxifene is a selective estrogen-receptor modulator (SERM ...
The pharmacokinetics of raloxifene were investigated in over 1500 women in clinical trials (Table 1). [16] Although most of the women were white and postmenopausal, interpatient variability of ...
A new federal mandate requires that all women undergoing mammography in the U.S. be informed about their breast density—a ...
A new federal mandate requires that all women undergoing mammography in the U.S. be informed about their breast density—a factor that affects both cancer detection and risk. The regulation ...
Hosted on MSN15d
What To Know About HR+/HER2- Breast CancerHR+/HER2- breast cancer—or hormone receptor-positive, HER2-negative breast cancer—is the most common subtype of breast cancer. It makes up about 70% of all breast cancer cases. HR+/HER2- breast cancer ...
President refers to non-profit investigating taxpayer-funded experiments on the effects of gender-affirming drugs in rodents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results